Pulmonary Disease, Chronic Obstructive Clinical Trials
3 recruiting trials for Pulmonary Disease, Chronic Obstructive. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Pulmonary Disease, Chronic Obstructive clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Necmettin Erbakan University (1), Imperial College London (1), University Hospital, Grenoble (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is health education (other, 1 trial), followed by Mobile application (Creating a WhatsApp group):, Telephone interview:.
Track Pulmonary Disease, Chronic Obstructive trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen...
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by persistent airflow obstruction and chronic respiratory symptoms or alpha-1-antitrypsin...
The London COPD Exacerbation Cohort
The London COPD exacerbation (EXCEL) cohort builds on an established cohort started in 1995 and designed to study COPD exacerbations and their impact on health-status and disease...
Neuromuscular Fatigue During Exercise in COPD-HF Overlap
Rationale. Chronic obstructive pulmonary disease (COPD) and heart failure (HF) coexist in approximately one third of patients presenting with one of these conditions. From a...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Pulmonary Disease, Chronic Obstructive, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Pulmonary Disease, Chronic Obstructive, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Pulmonary Disease, Chronic Obstructive, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.